StockData
Medpace Holdings, Inc. logo

Medpace Holdings, Inc. (MEDP) stock

MEDPNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 22, 2026Score 14/3042% above fair value
$646.87−6.22 (-0.95%)

Close on Nov 18, 2026Market cap $18.09BP/E 35.9Yield –

Medpace pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Medpace's pe ratio was 39.0× on Nov 11, 2026, against 41.4× a year earlier. Over the last 5 years it ranged from 22.5× to 45.5×, with a median of 32.2×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202639.0×−0.3
2025Dec 31, 202539.3×+10.2
2024Dec 31, 202429.1×−6.8
2023Dec 29, 202335.9×+3.3
2022Dec 30, 202232.6×−12.5
2021Dec 31, 202145.1×+2.5
2020Dec 31, 202042.6×+8.7
2019Dec 31, 201933.9×+2.2
2018Dec 31, 201831.7×−21.6
2017Dec 29, 201753.3×−247.3
2016Dec 30, 2016300.6×–

More Medpace figures

See a number that looks wrong?